World Antibiotic Awareness Week – an annual campaign supported by the World Health Organization – will take place in two weeks time, from 14th to 20th November 2016. The aim of the campaign is to “increase awareness of global antibiotic resistance and to encourage best practices among the general public, health workers and policy makers to […]

Approximately 11 hours from now, the United Nation General Assembly will host a “high level meeting” on antimicrobial resistance at the UN headquarters in New York. There will be statements by the UN secretary-general and the director-generals of the World Health Organization (WHO), Food and Agricultural Organization of the UN (FAO) and World Organization for […]

I read a recent review in Clinical Infectious Diseases (the second-ranked premier ID journal, depending on ranking criteria) on the World Health Organization’s (WHO’s) ranking of antibiotics a couple of days ago. The WHO has ranked antimicrobial agents according to their importance for human medicine since 2007, and has updated the list every 3 years or so. […]

Reading through several articles and reports on antimicrobial resistance, I came across a news story about a multidrug-resistant Pseudomonas outbreak linked to duodenoscopes at Huntington Memorial Hospital in the U.S.A. This is not the only outbreak linked to endoscopes this year – the more noteworthy event occurred at the Ronald Reagan UCLA Medical Centre, with 7 ill and 2 […]

The Society of Infectious Diseases (Singapore) has organised an annual infectious diseases clinical practice update for ID trainees and GPs/family medicine trainees for years. These practice updates are invariably organised by the trainees themselves, who have the liberty therefore to set the topics and invite the local consultants they would like to listen to. Somehow, I […]

The big news for antimicrobial resistance over the past week has been the decision by McDonald’s (the fast food chain) to use only antibiotic-free chicken in 2 years’ time. This will only affect the U.S. branches, although the company is also exploring phasing this in Europe. No signs of this happening in Singapore or the […]

A short summary of the current dilemma with antibiotic development. Others, including the World Health Organization and Infectious Diseases Society of America, have expressed this issue more elegantly and in greater detail (click on the links to check out), but it bears repeating: Drug discovery is tough. Discovering or creating a new (i.e. novel class of antibiotics) antibiotic […]